BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8992193)

  • 1. Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas.
    Kuliszkiewicz-Janus M; Baczyński S
    Magn Reson Med; 1996 Apr; 35(4):449-56. PubMed ID: 8992193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-induced changes in 31P-MRS (magnetic resonance spectroscopy) spectra of sera from patients with acute leukemia.
    Kuliszkiewicz-Janus M; Baczyński S
    Biochim Biophys Acta; 1997 Feb; 1360(1):71-83. PubMed ID: 9061042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma.
    Kuliszkiewicz-Janus M; Baczyński S
    NMR Biomed; 1995 May; 8(3):127-32. PubMed ID: 8580000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers.
    Kuliszkiewicz-Janus M; Janus W; Baczyński S
    Anticancer Res; 1996; 16(3B):1587-94. PubMed ID: 8694531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative expeditious analysis of phospholipid composition in human blood plasma by 31P NMR spectroscopy.
    Bradamante S; Barchiesi E; Barenghi L; Zoppi F
    Anal Biochem; 1990 Mar; 185(2):299-303. PubMed ID: 2339786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cholesterol and phospholipid concentrations in high-density lipoproteins by heparin-manganese chloride precipitation.
    Schwandt P; Weisweiler P
    Clin Chim Acta; 1979 Jul; 95(2):395-9. PubMed ID: 230919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and motion of phospholipids in human plasma lipoproteins. A 31P NMR study.
    Fenske DB; Chana RS; Parmar YI; Treleaven WD; Cushley RJ
    Biochemistry; 1990 Apr; 29(16):3973-81. PubMed ID: 2354169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
    Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
    Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
    Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
    Engan T; Bjerve KS; Høe AL; Krane J
    Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid-protein interactions in human low density lipoprotein detected by 31P nuclear magnetic resonance.
    Yeagle PL; Langdon RG; Martin RB
    Biochemistry; 1977 Jul; 16(15):3487-91. PubMed ID: 196635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of portacaval shunt on plasma lipids and lipoproteins in swine.
    Nestruck AC; Lussier-Cacan S; Bergseth M; Bidallier M; Davignon J; Marcel YL
    Biochim Biophys Acta; 1977 Jul; 488(1):43-54. PubMed ID: 196656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis.
    Baruch Y; Brook JG; Eidelman S; Aviram M
    Atherosclerosis; 1984 Nov; 53(2):151-62. PubMed ID: 6517971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of vascular hydrostatic pressure on the plasma concentrations of HDL-cholesterol, LDL-cholesterol and triglycerides in healthy subjects].
    Rodríguez Portillo M; Fabiani Romero F; Trujillo Rodríguez F
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):111-4. PubMed ID: 7313202
    [No Abstract]   [Full Text] [Related]  

  • 20. Location and interactions of phospholipid and cholesterol in human low density lipoprotein from 31P nuclear magnetic resonance.
    Yeagle PL; Martin RB; Pottenger L; Langdon RG
    Biochemistry; 1978 Jul; 17(14):2707-10. PubMed ID: 210780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.